Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (361-370 of 467) with videos related to

Pageof 47
Sort By:
Phlebology|November 26, 2020
Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreakDomenico Baccellieri, Luca Bertoglio, Luca Apruzzi, et al.
BMJ Open|February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b studySamit R Joshi, Ezequiel Cordova, Essack Mitha, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
European Journal of Clinical Investigation|October 27, 2021
Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19Francesco Melillo, Antonio Napolano, Marco Loffi, et al.
Andrology|November 21, 2023
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto studyPaolo Capogrosso, Alessandro Bertini, Marina Pontillo, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Pageof 47

Showing results (361-370 of 467) with videos related to

Sort By:
Pageof 47
Phlebology|November 26, 2020
Incidence of deep venous thrombosis in COVID-19 hospitalized patients during the first peak of the Italian outbreakDomenico Baccellieri, Luca Bertoglio, Luca Apruzzi, et al.
BMJ Open|February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b studySamit R Joshi, Ezequiel Cordova, Essack Mitha, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Ebiomedicine|August 23, 2024
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona)Valentina Mazzotta, Silvia Nozza, Simone Lanini, et al.
European Journal of Clinical Investigation|October 27, 2021
Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19Francesco Melillo, Antonio Napolano, Marco Loffi, et al.
Andrology|November 21, 2023
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto studyPaolo Capogrosso, Alessandro Bertini, Marina Pontillo, et al.
Open Forum Infectious Diseases|November 26, 2020
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO RegistryLaura Galli, Maria Rita Parisi, Andrea Poli, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Pageof 47